Ampio Pharmaceuticals, Inc.
AMPE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,658 | $2,562 | $113,600 | $274,826 |
| - Cash | $4,089 | $12,653 | $33,892 | $17,346 |
| + Debt | $274 | $803 | $1,194 | $1,209 |
| Enterprise Value | -$2,157 | -$9,288 | $80,902 | $258,689 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$250 | -$2,079 | -$1,094 | -$1,178 |
| % Margin | – | – | – | – |
| EBITDA | -$8,382 | -$23,159 | -$15,981 | -$14,585 |
| % Margin | – | – | – | – |
| Net Income | -$8,632 | -$16,337 | -$17,075 | -$15,894 |
| % Margin | – | – | – | – |
| EPS Diluted | -10.66 | -29.32 | -18.59 | -27.59 |
| % Growth | 63.6% | -57.7% | 32.6% | – |
| Operating Cash Flow | -$8,564 | -$21,128 | -$14,089 | -$14,729 |
| Capital Expenditures | $0 | $0 | -$97 | -$63 |
| Free Cash Flow | -$8,564 | -$21,128 | -$14,186 | -$14,792 |